REGN - Regeneron Pharmaceuticals, Inc.
IEX Last Trade
1184.19
5.260 0.444%
Share volume: 405,349
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1,178.93
5.26
0.45%
Fundamental analysis
57%
Profitability
68%
Dept financing
7%
Liquidity
72%
Performance
54%
Performance
5 Days
-1.20%
1 Month
9.92%
3 Months
22.14%
6 Months
19.96%
1 Year
41.89%
2 Year
101.34%
Key data
Stock price
$1,184.19
DAY RANGE
N/A - N/A
52 WEEK RANGE
$769.19 - $1,211.20
52 WEEK CHANGE
$0.42
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO: Leonard Schleifer
Region: US
Website: https://www.regeneron.com/
Employees: 12,099
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.regeneron.com/
Employees: 12,099
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Recent news